Benefits of Adherence to Psychotropic Medications on Depressive Symptoms and Antiretroviral Medication Adherence Among Men and Women Living with HIV/AIDS

Overview

Journal Ann Behav Med

Publisher Oxford University Press

Specialty Social Sciences

Date 2011 Nov 15

PMID 22076697

Citations 14

Authors

Dean G Cruess

Seth C Kalichman

Christine Amaral

Connie Swetzes

Chauncey Cherry

Moira O Kalichman

Affiliations

Soon will be listed here.

Abstract

Background: Psychotropic medications are commonly used for depressive symptoms among people living with HIV/AIDS.

Purpose: We examined the relationships between adherence to psychotropic medications, depressive symptoms, and antiretroviral adherence.

Methods: We assessed depressive symptoms among 324 people living with HIV/AIDS across a 3-month period (70% men; mean age 45 years; 90% African-American). Psychotropic and antiretroviral adherence was assessed using monthly, unannounced telephone pill counts. Multiple-regression and mediation analyses were utilized to examine associations under investigation.

Results: Greater depressive symptoms were associated with lower antiretroviral and psychotropic medication adherence. Greater adherence to psychotropic medications regardless of medication class was positively related to higher antiretroviral adherence. Greater adherence to psychotropic medications also significantly mediated the association between depressive symptoms and antiretroviral adherence.

Conclusions: This study demonstrates the benefits of adherence to psychotropic medications on both depressive symptoms and antiretroviral adherence. Future work examining psychotropic medication adherence on disease outcomes in people living with HIV/AIDS is warranted.

Citing Articles

Correlates of internalized stigma and antiretroviral therapy adherence among people living with HIV in the Volta region of Ghana.

Ouner J, Thompson R, Dey N, Alhassan R, Gyamerah A BMC Public Health. 2025; 25(1):342.

PMID: 39871213 PMC: 11773945. DOI: 10.1186/s12889-025-21500-5.

Global trends in depression among patients living with HIV: A bibliometric analysis.

Du X, Zhang Q, Hao J, Gong X, Liu J, Chen J Front Psychol. 2023; 14:1125300.

PMID: 36968702 PMC: 10036061. DOI: 10.3389/fpsyg.2023.1125300.

Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis.

Foley L, Larkin J, Lombard-Vance R, Murphy A, Hynes L, Galvin E BMJ Open. 2021; 11(9):e044987.

PMID: 34475141 PMC: 8413882. DOI: 10.1136/bmjopen-2020-044987.

Chronic distress and the vulnerable host: a new target for HIV treatment and prevention?.

Contoreggi C, Chrousos G, Di Mascio M Neurobehav HIV Med. 2021; 7:53-75.

PMID: 34295195 PMC: 8293862. DOI: 10.2147/nbhiv.s86309.

Mental Health in Women Living With HIV: The Unique and Unmet Needs.

Waldron E, Burnett-Zeigler I, Wee V, Ng Y, Koenig L, Pederson A J Int Assoc Provid AIDS Care. 2021; 20:2325958220985665.

PMID: 33472517 PMC: 7829520. DOI: 10.1177/2325958220985665.

References

Burnam M, Bing E, Morton S, Sherbourne C, Fleishman J, London A . Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001; 58(8):729-36. DOI: 10.1001/archpsyc.58.8.729. View

Leserman J . HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003; 54(3):295-306. DOI: 10.1016/s0006-3223(03)00323-8. View

Glass T, Battegay M, Cavassini M, de Geest S, Furrer H, Vernazza P . Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2009; 54(2):197-203. DOI: 10.1097/QAI.0b013e3181ca48bf. View

Kacanek D, Jacobson D, Spiegelman D, Wanke C, Isaac R, Wilson I . Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defic Syndr. 2010; 53(2):266-72. PMC: 2877126. DOI: 10.1097/QAI.0b013e3181b720e7. View

Nieuwkerk P, Oort F . Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005; 38(4):445-8. DOI: 10.1097/01.qai.0000147522.34369.12. View

Murphy E, Collier A, Kalish L, Assmann S, Para M, Flanigan T . Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001; 135(1):17-26. DOI: 10.7326/0003-4819-135-1-200107030-00005. View

Egger M, May M, Chene G, Phillips A, Ledergerber B, Dabis F . Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002; 360(9327):119-29. DOI: 10.1016/s0140-6736(02)09411-4. View

DAlessandro M, Conti C, Gambi F, Falasca K, Doyle R, Conti P . Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. J Clin Psychopharmacol. 2007; 27(1):58-61. DOI: 10.1097/JCP.0b013e31802f0dd1. View

Andresen E, Malmgren J, Carter W, Patrick D . Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994; 10(2):77-84. View

10.

Bing E, Burnam M, Longshore D, Fleishman J, Sherbourne C, London A . Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001; 58(8):721-8. DOI: 10.1001/archpsyc.58.8.721. View

11.

Bangsberg D . Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006; 43(7):939-41. DOI: 10.1086/507526. View

12.

Hogg R, Yip B, Chan K, Wood E, Craib K, OShaughnessy M . Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA. 2001; 286(20):2568-77. DOI: 10.1001/jama.286.20.2568. View

13.

Himelhoch S, Medoff D . Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis. AIDS Patient Care STDS. 2005; 19(12):813-22. DOI: 10.1089/apc.2005.19.813. View

14.

Hammer S, Squires K, Hughes M, Grimes J, Demeter L, Currier J . A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997; 337(11):725-33. DOI: 10.1056/NEJM199709113371101. View

15.

Ickovics J, Hamburger M, Vlahov D, Schoenbaum E, Schuman P, Boland R . Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001; 285(11):1466-74. DOI: 10.1001/jama.285.11.1466. View

16.

Morrison M, Petitto J, Ten Have T, Gettes D, Chiappini M, Weber A . Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry. 2002; 159(5):789-96. DOI: 10.1176/appi.ajp.159.5.789. View

17.

Arnsten J, Li X, Mizuno Y, Knowlton A, Gourevitch M, Handley K . Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users. J Acquir Immune Defic Syndr. 2008; 46 Suppl 2:S64-71. DOI: 10.1097/QAI.0b013e31815767d6. View

18.

Atkinson Jr J, Grant I, Kennedy C, Richman D, Spector S, McCutchan J . Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. Arch Gen Psychiatry. 1988; 45(9):859-64. DOI: 10.1001/archpsyc.1988.01800330091011. View

19.

Evans D, Have T, Douglas S, Gettes D, Morrison M, Chiappini M . Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry. 2002; 159(10):1752-9. DOI: 10.1176/appi.ajp.159.10.1752. View

20.

Sambamoorthi U, Walkup J, Olfson M, Crystal S . Antidepressant treatment and health services utilization among HIV-infected medicaid patients diagnosed with depression. J Gen Intern Med. 2000; 15(5):311-20. PMC: 1495453. DOI: 10.1046/j.1525-1497.2000.06219.x. View